Fundraising FoxZZ Biotech
Houston, US · 1 known investors
Find your way into ZZ Biotech
Sign up to see every warm intro you have to ZZ Biotech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ZZ Biotech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ZZ Biotech develops 3K3A-APC, a genetically engineered variant of human activated protein C (a serine protease) optimized for therapeutic use. The company has agreed in principle to license its 3K3A-APC dermatology program to Dermatherix for wound therapy applications.
Investors · 1
Broadview Ventureslisted by Broadview VenturesBoston
How we know: Broadview Ventures's portfolio page · a partner's Signal profile · Not right? Tell us
Frequently asked questions
- What does ZZ Biotech do?
- ZZ Biotech develops 3K3A-APC, a genetically engineered variant of human activated protein C (a serine protease) optimized for therapeutic use. The company has agreed in principle to license its 3K3A-APC dermatology program to Dermatherix for wound therapy applications.
- Who are ZZ Biotech's investors?
- ZZ Biotech's investors include Broadview Ventures.
- Where is ZZ Biotech headquartered?
- ZZ Biotech is headquartered in Houston, US.